Virus News and Research

Latest Virus News and Research

Views on AIDS: More funding will be needed for new attack on HIV; The epidemic hits hard in the South

The international AIDS conference in Washington has already made two points clear. There is no prospect that scientists will any time soon find the ultimate solutions to the AIDS epidemic, namely a vaccine that would prevent infection with the AIDS virus or a "cure" for people already infected with the virus.

31 Jul 2012

Ebola outbreak identified in Uganda

"The world's first major outbreak of Ebola hemorrhagic fever since 2009 has killed at least 14 of 20 people infected in a remote area of midwestern Uganda," the Wall Street Journal reports (Bariyo/McKay, 7/29).

30 Jul 2012

Progress with GSK in advancing VaxiRNA technology earns Alnylam $3.2M milestone payment

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has earned a development milestone payment from GlaxoSmithKline, totaling $3.2 million. The milestone payment is related to progress in the companies' collaboration on the use of VaxiRNA technology for the production of GSK influenza vaccine.

30 Jul 2012

Some AIDS experts view health law coverage expansion with hope

Meanwhile, the Obama administration announced it would add new funds to increase access to HIV/AIDS care, but questions remain about whether it will be enough to address waiting lists for the drug assistance program. Also in the news, reports on treatment developments.

30 Jul 2012

EASL calls on the UN to take action to fight against viral hepatitis infection

Marking World Hepatitis Day, the European Association for the Study of the Liver (EASL) calls on the different organizations which make up the United Nations systems to take action to fight against Viral Hepatitis (Hepatitis B and C), a potentially fatal infection of the liver which affects 500 million people.

30 Jul 2012

Study examines how heterosexual men with HIV seek health care and support services

Heterosexual men make up a small but growing number of people infected with HIV in Canada. Yet a new study has found that many of them feel existing HIV-related programs and services don't meet their needs and are geared primarily or exclusively toward gay men and heterosexual women who are living with the virus.

30 Jul 2012

Health systems must prepare for aging population living with HIV

"Many health systems are not ready to cope with the relatively new phenomenon" of people living with HIV (PLHIV) growing older, PlusNews reports. "Data on aging with HIV is largely restricted to the developed world and very little is known about older Africans living with virus, despite the high caseload in this region," the news service writes, adding, "A July 2012 supplement of the medical journal, AIDS, notes that an estimated three million people in sub-Saharan Africa aged 50 and older are HIV-positive -- 14 percent of all infected adults.

30 Jul 2012

Early ART treatment delays AIDS-related health events in HIV-infected individuals

Further analyses of the landmark NIH-funded treatment-as-prevention study (HPTN 052) have found that providing antiretroviral treatment to HIV-infected individuals earlier, when their immune systems are healthier, delays AIDS-related health events, such as chronic herpes simplex virus and tuberculosis, as well as death. Additionally, researchers found that earlier HIV treatment is also cost-effective because it increases survival, prevents costly opportunistic infections and averts transmission of the virus to uninfected individuals.

30 Jul 2012

Recent release: AIDS response should be 'instrument for social justice'

"It is outrageous that, in 2012, when we have everything we need to beat AIDS, we are still fighting prejudice, stigma, and exclusion," UNAIDS Executive Director Michel Sidibe writes on the Human Rights and HIV/AIDS "Now More Than Ever" blog, adding, "It is my daily reminder that the AIDS response is not just about an epidemic; the AIDS response is, has been, and must be, an instrument to fight for social justice."

28 Jul 2012

Research presented at AIDS 2012 conference renews hope of cure for AIDS

Two studies presented at the XIX International AIDS Conference (AIDS 2012) and one published Wednesday in the British journal Nature "have given researchers renewed hope that a cure for AIDS may be possible," the Washington Post reports.

28 Jul 2012

Experimental dengue vaccine protects against 3 of 4 viral strains, study results show

"The world's first vaccine against dengue fever, being developed by French drugmaker Sanofi SA, protected against three of the virus's four strains in a keenly awaited clinical trial in Thailand," the company announced on Wednesday, Reuters reports.

28 Jul 2012

NPR examines whether goal of treating all HIV-positive people with ARVs is feasible

Noting new guidelines released at the XIX International AIDS Conference (AIDS 2012) in Washington, D.C., this week "call for everybody with HIV to be started on antiretroviral drugs [ARVs] as soon as they test positive for the virus," NPR's "Shots" blog examines "whether the goal is achievable, and who would pay for this enormous expansion in treatment."

27 Jul 2012

Viral evolution and host protein levels predict rapid disease progression in hepatitis C patients

Scientists at the National Institutes of Health have identified several factors in people infected with the hepatitis C virus that may predict whether the unusually rapid progression of disease from initial infection to severe liver conditions, such as cirrhosis, will occur. Knowing whether a patient's condition is likely to deteriorate quickly could help physicians decide on the best course of treatment.

27 Jul 2012

AIDS roundup: Researchers examine whether the disease causes premature aging; Funding and treatment gaps; Bone marrow transplant treatments

News outlets report on scientific and political issues coming up at the International AIDS Conference being held in Washington.

27 Jul 2012

Vaccine complex delivered safely by piggybacking onto 3D DNA nanostructures

In a quest to make safer and more effective vaccines, scientists at the Biodesign Institute- at Arizona State University have turned to a promising field called DNA nanotechnology to make an entirely new class of synthetic vaccines.

27 Jul 2012

A key question at this week's AIDS Conference: Who will pay the worldwide costs of treatment?

A roundup of news from the International AIDS Conference taking place this week in Washington.

27 Jul 2012

Lymphoma drug dislodges hidden virus in HIV patients

Researchers from the University of North Carolina at Chapel Hill have published pioneering research showing that a drug used to treat certain types of lymphoma was able to dislodge hidden virus in patients receiving treatment for HIV.

27 Jul 2012

HIV drug resistance: an interview with Dr. Silvia Bertagnolio

Sexual intercourse is the major mode of HIV transmission. HIV may also be transmitted through sharing of needles or contaminated blood products (although this is rare).

27 Jul 2012

WHO announces efforts to fight 'hidden epidemic' of hepatitis

Ahead of World Hepatitis Day on July 28, the WHO "announced on Wednesday measures to fight the 'hidden epidemic' ... which kills more than one million people a year," Agence France-Presse reports. The virus "affects 500 million people worldwide but can go unnoticed for years and even decades," the news service reports.

27 Jul 2012

Bone marrow transplant eradicates traces of HIV in men

Two men with longstanding HIV infections no longer have detectable HIV in their blood cells following bone marrow transplants. The virus was easily detected in blood lymphocytes of both men prior to their transplants but became undetectable by eight months post-transplant. The men, who were treated at Brigham and Women's Hospital (BWH), have remained on anti-retroviral therapy.

27 Jul 2012

Virus News and Research

Latest Virus News and Research

Views on AIDS: More funding will be needed for new attack on HIV; The epidemic hits hard in the South

Ebola outbreak identified in Uganda

Progress with GSK in advancing VaxiRNA technology earns Alnylam $3.2M milestone payment

Some AIDS experts view health law coverage expansion with hope

EASL calls on the UN to take action to fight against viral hepatitis infection

Study examines how heterosexual men with HIV seek health care and support services

Health systems must prepare for aging population living with HIV

Early ART treatment delays AIDS-related health events in HIV-infected individuals

Recent release: AIDS response should be 'instrument for social justice'

Research presented at AIDS 2012 conference renews hope of cure for AIDS

Experimental dengue vaccine protects against 3 of 4 viral strains, study results show

NPR examines whether goal of treating all HIV-positive people with ARVs is feasible

Viral evolution and host protein levels predict rapid disease progression in hepatitis C patients

AIDS roundup: Researchers examine whether the disease causes premature aging; Funding and treatment gaps; Bone marrow transplant treatments

Vaccine complex delivered safely by piggybacking onto 3D DNA nanostructures

A key question at this week's AIDS Conference: Who will pay the worldwide costs of treatment?

Lymphoma drug dislodges hidden virus in HIV patients

HIV drug resistance: an interview with Dr. Silvia Bertagnolio

WHO announces efforts to fight 'hidden epidemic' of hepatitis

Bone marrow transplant eradicates traces of HIV in men

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in